| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Mitomycin C is a broad-spectrum antitumor antibiotic isolated and extracted from the culture solution of Streptomyces cephalans. It has anticancer effects on a variety of cancers. Its mechanism of action can depolymerize the DNA of cells and hinder DNA replication, thereby inhibiting tumors. Cell division.
On October 27, 2017, the list of carcinogens published by the International Agency for Research on Cancer of the World Health Organization was preliminarily arranged for reference, and mitomycin C was included in the list of 2B carcinogens.
|
Foreign name Mitomycin C (MMC) Aliases: Self-immobilization Molecular formula C15H18N4O5 Molecular weight 334.327g/mol CAS No.[50-07-7] Main indications Tumor, gastrointestinal cancer, lung cancer, breast cancer, cervical cancer, etc. Adverse reactions Bone marrow suppression, loss of appetite, nausea and vomiting, hair loss, etc. |
){kind=link}